To quantitatively evaluate the extent to which fiducial-based image-guidance improves dose coverage of the target volume and sparing of critical organs for prostate cancer patients treated with intensity modulated radiotherapy (IMRT) and determination of planning margins by original approach of detailed daily dose volume histogram (DVH) and patient's position correction analysis. Sixty-two patients divided in two groups (clinical target volume (CTV) → planning target volume (PTV) margin 10 and 7 mm) were treated with IMRT using implanted fiducial markers. Each patient's treatment fraction was recalculated as it would have been treated without fiducial-guided positioning. For both plans (IGRT and non-IGRT), equivalent uniform doses (EUD), maximal and minimal doses for target volumes, normal tissue complication probability (NTCP), maximum and mean doses for organs at risk and the whole DVH differences were assessed. In the group with 10 mm margins, the only significant difference was worse rectal NTCP by 4.5%, but the CTV dose coverage remained at the same level.
Introduction
Intensity modulated radiotherapy (IMRT) is a standard treatment method for localized prostate cancer. Results of IMRT for prostate cancer strongly depend in part on the prescribed dose (1, 2) and precise target volume positioning (3, 4) . In order to escalate doses above 70 Gy as recommended (5) , there must be certainty that organs at risk do not lie within the high-dose region. Correct setup keeps dose distributions to the target volume and organs at risk as intended at the time of planning, while imprecise setup leads to "blurring" of the high dose region over critical structures and could cause underdosing of the target volume. The dose distribution and thereby the shape of dose volume histogram (DVH) predicts rectum and bladder complication risk, such as late rectal bleeding (6, 7) .
To ensure that the patient's position on the treatment couch is correct with regard to isocentre, several techniques including visualizing target volume itself were developed. The better the target volume is located, the smaller the safety margin that needs to be applied to the clinical target volume (CTV) (8) . Smaller safety margins reduce the potential for toxicity to organs at risk while achieving the same curative potential (9, 10) . To determine a sufficient margin it is necessary to study prostate movements and patient's setup method accuracy. At many institutions, to correct the patient's position on the treatment couch, three to four fiducial markers are routinely implanted into the prostate before radiotherapy starts. Before each fraction, a setup procedure consists of two orthogonal kV on-board imaging (OBI) and isocentre alignment by comparing fiducial markers position on actual images to digitally reconstructed radiograph (DRR) created from the planning CT. Although couch position corrections are typically 1 cm (11) , this shift could be crucial to maintain the prescribed dose to planning target volume (PTV) and remain below tolerance levels of critical structures.
In the present study we tried to quantify how much imageguidance with intraprostatic fiducial markers could improve dose coverage of target volume and critical organs sparing for prostate cancer patients treated with IMRT, in contrast to laser-tattoo alignment, using daily DVH analysis.
Patients and Methods

Patients
Sixty-two patients with localized T1c-T3b prostate adenocarcinoma treated with definitive external beam IMRT at our department were retrospectively studied. All patients underwent implantation of three gold markers under short intravenous general anesthesia one week prior to treatment planning. The position of marker implantation was controlled under transrectal ultrasound with a brachytherapy grid. One fiducial marker was placed in the apex of the prostate and two markers were each placed in the left and right prostatic base. This pattern assures favorable marker distribution over the entire prostate volume for 3D visualization.
A treatment planning transversal CT (Siemens AG, Erlangen, Germany) scan with 3 mm spacing was performed one week after the implant procedure due to reduce the impact of bleeding, inflammation, or edema. A rectal and bladder filling protocol was used to keep the rectum empty during the planning CT and at each treatment session. Patients were instructed to undergo planning CT with empty rectum (using laxative) and mildly full bladder (urination 45 min before planning CT and drinking 0.5-l water). If the rectum diameter on planning CT exceeded 6 cm, the process was repeated. Patients were instructed to keep to these rules all the irradiation period.
CTV consisted of prostate in low-risk patients and prostate plus seminal vesicles bases in intermediate-risk and high-risk patients.
We used 10 mm margin for CTV to obtain PTV in pre-IGRT era in our department, so we maintain this extent in first thirty-one IGRT patients that we included in our study. After getting some experience with IGRT system, the PTV was delineated as CTV plus a 7 mm margin (value based on average setup corrections of previous patients and verified to not to be lower than margin based on van Herk formula for 95% minimum dose to CTV for 90% of patients (12)) for the following thirty-one patients. All patients underwent IMRT with five coplanar fields at gantry angles of 45°, 100°, 180°, 260° and 315°. The prescription dose was 78 Gy in 39 fractions to the PTV, five times per week. All plans were optimized to meet criteria given in Table I . Isocentre positioning on the treatment couch was performed first using body tattoos and laser alignment. Our staff was instructed to set the patient as carefully as possible; with no regard that another set up control would be performed. Afterward, two orthogonal (gantry 0° and 270°) kV (OBI; Varian Medical Systems, Palo Alto, CA, USA) were acquired every fraction. Patient position was corrected before the irradiation starts (online) in accordance to the reference DRR. By that procedure we obtained set up corrections adjusting laser-tattoo set up errors and interfraction organ motions. Every pair of kV images was carefully evaluated by trained professional after radiotherapeutic session (offline) to find imprecision in online patient setup errors made by staff in the time of online position corrections due to lack of time etc.
We noticed maximal and minimal doses too. For rectum and bladder we used radiobiological concept of normal tissue complication probability (NTCP) as Burman published (14). We adopted fit parameters from this publication related to symptomatic bladder contracture and volume loss and rectum proctitis, necrosis, stenosis or fistula. We logged maximal and average doses in addition. For volume called normal tissue, which contains the whole body except for PTV, maximal and average doses were recorded.
All the parameters were assessed with paired t-test for IGRT and non-IGRT plan couple for patients with CTV to PTV margin 10 and 7 mm separately. The normality of data distribution in all parameters was confirmed by D'Agostino analysis (15) . We considered p  0.05 to be statistically significant.
We performed detailed DVHs comparison to find areas, where the shape of DVH is significantly different in original (IGRT) and recalculated (non-IGRT) plan for every patient. This analysis was calculated with paired t-test in 0.25 Gy steps from 0 to maximum dose and values of irradiated volumes were compared.
Every patient's online alignments data were used to calculate necessary CTV → PTV margins to maintain real dose for CTV following Stroom's formula (16) [2] in the situation without IGRT.
M 5 resulting margin  tot 5 systematic set up error within the whole radiotherapy course s tot 5 random set up error within the whole radiotherapy course
The same calculation method was used for offline alignment data to calculate minimal margin when IGRT is used to compensate set up errors occurring within online corrections.
Treatment Plans
For DVH comparisons between image guided and lasertattoo isocentre setup, each fraction of the original treatment plan calculated on base of planning CT slices and planning structures delineation was re-evaluated following image guided markers' alignment. At first the original isocentre used for planning and irradiation was relocated inversely with reference to the recorded online couch shift for every patients' fraction separately. This fraction was then recalculated the same way as originally planned, with no changes in delineation, multileaf collimator movement or monitor unit count to obtain dose distribution in the case of no IGRT set up. All thirty-nine shifted and recalculated fractions were then summed to obtain the estimate of the treatment plan that would have been delivered to the one patient in the absence of image-guidance. This procedure was repeated for all remaining patients to gain sixty-two pairs of treatment plans, one really irradiated with IGRT guidance (IGRT plan) and other virtually irradiated without IGRT guidance (non-IGRT).
Evaluation
The DVHs for each pair of treatment plans (original IGRT and recalculated non-IGRT) for each patient were exported and evaluated. In addition, the following parameters were calculated:
For PTV and CTV, we calculated equivalent uniform dose (EUD) following generalized Niemierko formula with exponent a 5 210 to accommodate negative influence of coldspots to the radiotherapy curative potential (13) [1] .
[1]
EUD 5 equivalent uniform dose v i , D i 5 partial volume v i with absorbed dose D i a 5 tumor specific parameter describing the dose volume effect 
Results
In the cohort with 10 mm CTV → PTV margin, statistically significant changes in PTV dose coverage were observed. In non-IGRT plans, the PTV EUD was decreased by 2.1 Gy on average (p  0.001), dose maximum by 0.4 Gy on average (p 5 0.002) and dose minimum by 11.2 Gy in average (p  0.001). Maximum dose to the CTV was decreased by 0.4 Gy in average too (p  0.001). No more significant changes in target dose coverage were found. Regarding critical structures, rectal NTCP was increased by 4.5% (p  0.001). No changes in bladder dose parameters were observed. Maximum doses to the structure "normal tissue" were increased by 0.4 Gy (p 5 0.01).
For patients with a 7 mm CTV → PTV margin, a statistically significant decrease in EUD, maximal and minimal doses to PTV and CTV were observed in non-IGRT plans. PTV EUD was decreased by 3.7 Gy (p  0.001), maximum dose to PTV was 0.5 Gy lower (p  0.001), minimum dose to PTV was 16.0 Gy lower (p  0.001), CTV EUD was decreased by 0.6 Gy (p  0.001), maximum dose to CTV was decreased by 0.5 Gy (p  0.001) and minimum dose to CTV was 2.6 Gy lower (p  0.001). Other significant changes were in maximum doses to rectum (0.7 Gy lower in recalculated plans, p 5 0.02) and normal tissue (0.7 Gy higher in recalculated plans, p 5 0.004) (Figure 2 , Tables II-V) .
To guarantee 95% instances when delivered dose to CTV maintain as planned were margins determined as follows: 10, 12 and 11 mm along anterior-posterior (A-P), cranio-caudal (C-C) and left-right (L-R) axes, respectively, when IGRT is not available and 2, 2 and 1 mm, respectively, when IGRT is used every fraction.
Discussion
Using fiducial markers and kV imaging for prostate cancer is a standard method to ensure precise patient positioning, because of the speed and ease of interpretation compared to other methods (17) . Our results showed, that for large CTV → PTV (10 mm) margins, image-guidance has no noticeable benefit for target volume coverage. We did find that PTV EUD was significantly lower without image-guidance, but without an appreciable clinical impact for patients, since the CTV coverage maintained at the same level. The 10 mm CTV → PTV margin is comparable to recommended values for IMRT without image-guidance (18, 19) , therefore we believe that this margin extent is not appropriate for IMRT with precise patient setup. Stricter rule results from systematic and random errors analysis, where 95% instances of delivered dose maintain as planned when margins up to 12 mm would be applied. We guess that these two results aren't in contradiction, because EUD is dose-distribution simplifying parameter and therefore results from EUD analysis are less strict. In the plans with 7 mm margins, the situation was different because of the significant changes in PTV and CTV parameters (EUD, maximal and minimal dose). Some studies based on average population data as TCP also show, that benefit of IGRT is not so noticeable for margins up to 5 mm (20) , but our study based on concrete measured data for every single patient shows IGRT benefit for patients with 7 mm margins in the EUD and dose coverage issue. Although there are many studies supporting a clinical benefit of IMRT dose escalation in prostate cancer, EUD parameters have not been studied in this setting to the best of our knowledge; except for one study of low dose-rate brachytherapy in low-risk prostate cancer (21) .
We observed no difference in bladder parameters (NTCP, maximum a mean doses), but the irradiated volumes were slightly higher in recalculated plans for both cohorts. Unfortunately, the association of DVH parameters with late urinary toxicity seems problematic because of changes in bladder filling (22) and there are few studies which have confirmed this DVH-toxicity relationship (23, 24) .
The connection between late rectal toxicity and DVH parameters is well documented (25) (26) (27) . Therefore, fiducial-guidance appears favorable for rectal sparing, especially in the high dose region between 50-68 Gy (the area of rectal located close to the PTV but not within the PTV). The only parameter, which supports fiducial usage in patients when large (10 mm) margins are used is rectal NTCP, which was increased by 4.5% without fiducial usage. To apply these results we assume no major differences in rectal filling between planning and fraction delivery, and provide patients with dietary instruction to minimize rectal distention (28) .
IGRT with gold markers could not guarantee exactly the same level of bladder and rectum irradiation because of their shape and filling changes. Analysis of patient's setup corrections showed some cases of apparent rectum or bladder dose decrease, if IGRT wouldn't be used. For example, if the patient comes to his treatment session with full bladder, prostate and rectum are pushed anteriorly and without IGRT bladder overirradiation and rectum underirradiation occurs. This situation couldn't be explained as a rectum dose improvement, but it remains to be incorrect irradiation.
The IGRT with gold markers guidance seems to be so precise, that the planning margins could be reduced to 2 mm, but this value reflects only interfraction prostate motion. There should be margins for intrafraction motion added for clinical use.
Conclusions
For large (10 mm) CTV to PTV margins, image-guidance with fiducials has no noticeable benefit for CTV coverage and normal tissue sparing. On the contrary, an even 10 mm margin seems to be insufficient without image-guidance. For reduced (7 mm) margins, it is not possible to achieve planned CTV and PTV EUD without using fiducials. There are no changes in bladder and rectal NTCP between plans with and without image-guidance, but improvements in NTCP would be achieved by reducing margins below 7 mm. Prostate IMRT strategies involving margin reductions below 7 mm require image-guidance to maintain planned dose coverage. Minimal margin of 2 mm is needed with fiducial image-guidance to prevent interfraction prostate motion. Larger margins are needed to avoid intrafraction movement. On the other hand, using fiducial-based image-guidance with margins 10 mm seems to be superfluous.
